T. Rowe Price International Equity Index Fund

100 East Pratt Street,
Baltimore , MD, 21202

Rank

Rank Universe

Summary

The fund seeks capital appreciation in the long term by investing in companies outside the United States.

The sub-adviser’s investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team utilizes a replication strategy, which involves investing substantially in the se More

Link

Directors

Jan 12, 2024
  • Bruce W. Duncan
  • David Oestreicher
  • Eric L. Veiel
  • Kellye L. Walker
  • Mark J. Parrell
  • Melody Bianchetto
  • Paul F. McBride
  • Robert J. Gerrard, Jr.
  • Teresa Bryce Bazemore

Chief Compliance Officer

  • Armando Capasso

Fund Manager(s)

Price

  • $ 16.72 ( +0.02 )
    Nov 4, 2024
    Last Close
  • Net Assets
  • $863.4M
    Mar 28, 2024
  • Holding
  • 753
    Sep 27, 2024
    More

  • 52-Week High/Low
  • $17.81 - $14.48
  • Turnover
  • 14.2%
  • Expense Ratio
  • 0.26%

Company Name

Holding

T. Rowe Price Government Reserve Fund 2.86 %
Novo Nordisk A/S 2.47 %
T. Rowe Price Government Reserve Fund 2.21 %
ASML Holding NV 2.13 %
Nestle SA 1.54 %
AstraZeneca PLC 1.41 %
Shell PLC 1.34 %
Roche Holding AG 1.3 %
SAP SE 1.26 %
Novartis AG 1.25 %
More 1.25 %

Advisor

Documents

Prospectus

Annual Reports

Performance

YTD

0.7%

3 Year

-2.39%

5 Year

18.41%

Best

38.08%

2003

Worst

-21.36%

2001

Alpha

PIEQX S&P 500

Chart +